Recent Finacing
Recent Raise
DTx Pharma develops RNA-based therapeutics using its FALCON fatty-acid delivery platform to enable oligonucleotide uptake across retina, muscle, heart, neurons, and immune cells, advancing preclinical assets toward clinical studies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
